<SEC-DOCUMENT>0000950123-18-006151-index.html : 20180606
<SEC-HEADER>0000950123-18-006151.hdr.sgml : 20180606
<ACCEPTANCE-DATETIME>20180606080148
ACCESSION NUMBER:		0000950123-18-006151
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20180606
DATE AS OF CHANGE:		20180606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224840
		FILM NUMBER:		18882950

	BUSINESS ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>achv-s1A.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: achv-s1A.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>2
<FILENAME>achv-ex231_6.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: achv-ex231_6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g201806060753451581870.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g201806060753451581870.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g201806060753452421871.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g201806060753452421871.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g201806060753556351872.jpg
<TEXT>
Document 5 - file: g201806060753556351872.jpg

</DOCUMENT>
</SEC-DOCUMENT>